Kyoto University and information and communications technology company Fujitsu are teaming up on a project that will use artificial intelligence (AI) within medicine.
Brain chip
The two organisations have developed the Department of Medical Intelligent Systems at the Kyoto University Graduate School of Medicine.
The joint research project will use medical information collected by Kyoto University Hospital and the Fujitsu Group's advanced AI technology, Fujitsu Human Centric AI Zinrai, to accelerate R&D towards advanced, next-generation medicine.
Fujitsu and Kyoto University will use the database platform to analyse large volumes of medical data to discover new treatments and diagnostic methods, whilst also potentially improving the quality of care.
The project will run from January 2018 to March 2020 and will use consented medical data including patient data collected on electronic medical records, cancer patient data from Kyoto University and cohort data.
The data will be preprocessed using natural language processing and then an environment for analysis will be created. The researchers will then use machine learning to extract the common characteristics for diseases and will create models that benefit diagnostic support, including the identification of specific disease characteristics from medical images, and the discovery of next-generation drugs.
Fujitsu intends to utilise the platform in the future in other areas besides medicine and anticipates it will be useful within the fields of manufacturing and finance.
